These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1673792)

  • 41. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.
    Devilee P; van den Broek M; Kuipers-Dijkshoorn N; Kolluri R; Khan PM; Pearson PL; Cornelisse CJ
    Genomics; 1989 Oct; 5(3):554-60. PubMed ID: 2575586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.
    Coles C; Thompson AM; Elder PA; Cohen BB; Mackenzie IM; Cranston G; Chetty U; Mackay J; Macdonald M; Nakamura Y
    Lancet; 1990 Sep; 336(8718):761-3. PubMed ID: 1976143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
    Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma.
    Foulkes WD; Black DM; Stamp GW; Solomon E; Trowsdale J
    Int J Cancer; 1993 May; 54(2):220-5. PubMed ID: 8098014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
    Børresen AL; Hovig E; Smith-Sørensen B; Malkin D; Lystad S; Andersen TI; Nesland JM; Isselbacher KJ; Friend SH
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8405-9. PubMed ID: 1924299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
    Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
    Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
    Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
    Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
    Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumors.
    Callahan R; Cropp C; Sheng ZM; Merlo G; Steeg P; Liscia D; Lidereau R
    J Cell Biochem Suppl; 1993; 17G():167-72. PubMed ID: 8007695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.
    Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR
    Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromosomal localization of putative tumor-suppressor genes in several human cancers.
    Yokota J; Sugimura T; Terada M
    Environ Health Perspect; 1991 Jun; 93():121-3. PubMed ID: 1685440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
    Deng G; Lu Y; Zlotnikov G; Thor AD; Smith HS
    Science; 1996 Dec; 274(5295):2057-9. PubMed ID: 8953032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M; Kawashima A; Mai M; Ooi A
    Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
    Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
    Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations in p53 as potential molecular markers for human breast cancer.
    Runnebaum IB; Nagarajan M; Bowman M; Soto D; Sukumar S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10657-61. PubMed ID: 1961733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms.
    Dockhorn-Dworniczak B; Poremba C; Dantcheva R; Stücker A; Brömmelkamp E; Blasius S; Mellin W; Roessner A; Yandell DW; Böcker W
    Virchows Arch; 1994; 424(4):337-42. PubMed ID: 7911380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma.
    Uchida T; Wada C; Shitara T; Egawa S; Mashimo S; Koshiba K
    J Urol; 1993 Oct; 150(4):1298-301. PubMed ID: 8103806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.